FDA Inspection 1156013 — Friese, David

Friese, David — FEI 3020194961

The FDA completed an inspection of Friese, David on Nov 2, 2021 in Wanamingo, MN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 2, 2021
Fiscal Year
2022
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Wanamingo, MN (United States)

Citations

IDCFRDescription
1352121 CFR 530.41(a)Drugs prohibited for extralabel use in food-producing animal(s)
4185FDCA 402(a)(4)Record keeping